Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
SUPERMARKET chain Asda will donate £100,000 to food redistribution charity FareShare to support Muslim charities and community groups across the UK during Ramadan.
Through this partnership, Asda enables hundreds of vulnerable families access to food, which might otherwise have gone to waste, through the 11,000 charities and community groups FareShare supports, the company said in a statement.
Besides, community champions will be able to donate £10,000 worth of food and goods to support Muslim communities locally through Asda stores.
Jo Warner, Asda’s senior director of community said: “Through our work with FareShare, we’re supporting vulnerable families and providing meals to those most in need. Food is to be shared and enjoyed and is often a central part of bringing communities together, especially during important religious festivals such as Ramadan.
"I know many are hoping for a small family gathering to share pre-fasting and post-fasting meals as restrictions ease and this donation will enable community groups to provide food and support for so many families that may be struggling with food security."
Asda invested in FareShare’s infrastructure over the past three years through its 'Fight Hunger Create Change' programme.
The retailer had funded new warehouses and refits which helped the charity to redistribute an additional 71 million meals since 2018 and support an additional 4000 charities to be able to receive food donations, the statement added.
Lindsay Boswell, FareShare chief executive, said: “Demand for our service has never been higher and unfortunately we anticipate it will remain high for some time – but thanks to the support of Asda, we’re proud to be working hard to get good food to Muslim communities and faith groups throughout the Ramadan and all year round.”
Andy Brown, community development leader at Oasis Hub Hobmoor, which is served by FareShare Midlands, said: “When the schools were closed from March to August, we basically turned it into a food distribution hub, delivering about 200 food parcels every week.
"Our aim is that no child or adult, no one in Yardley, should go hungry. We’ve heard back from people that the delivery service was really a lifeline, people couldn’t have survived without it and there is still a huge need out there.”
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.